NDRA   $0.2  -4.76% Market Closed After Close 0.219 9.50%

ENDRA Life Sciences Inc
Total Cash 6.40M
totalCashPerShare 4.418
EBITDA -9.52M
Total Debt 549.13K
quickRatio 4.741
currentRatio 4.972
Total Revenue
debtToEquity 6.106
Revenue/Share
ROA -0.60942
ROE -1.20132
grossProfits
freeCashflow -2.48M
operatingCashflow -9.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -5.55M
forwardPE -0.02325477
floatShares 1.45M
sharesOutstanding 18.14M
sharesShort 268.05K
sharesShortPriorMonth 184.18K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.13%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 6.208
Price To Book help_outline 0.03
earningsQuarterlyGrowth
netIncomeToCommon -9.57M
trailingEps -32.00%
forwardEps -8.91%
enterpriseToEbitda 0.58
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.78 3Q 2024
institutionsCount 15
lastUpdated Oct. 16, 2024, 6:53 p.m.